Molecular subtypes and genetic alterations may determine response to lung cancer therapy
Friday, May 11, 2012 - 18:50
in Health & Medicine
Scientists have just shown that lung cancer molecular subtypes correlate with distinct genetic alterations and with patient response to therapy. These findings in pre-clinical models and patient tumor samples build on their previous report of three molecular subtypes of non-small cell lung cancer and refines their molecular analysis of tumors.